Figure 3From: Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey Probability of cost saving curve from the Monte Carlo Simulation sensitivity analyisis of voriconazole (Vori) versus liposomal amphotericin B (LAmB) per patient treated. Back to article page